Michael Poser
Hospitalist · Madison, WINPI 1497315923
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 72 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 21.8% — the pattern of someone who eats at a lot of different presentations. Among hospitalist clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 72 payments — averaging $16.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$263
- Dexcom, Inc.$175
- Boehringer Ingelheim$141
- Novo Nordisk$132
- Lilly USA, LLC$119
- Melinta Therapeutics, LLC$62
- plus $316 from 14 others
What the payments were for
- Food & beverage$1,209100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 17 | $263 |
| Dexcom, Inc. | 9 | $175 |
| Boehringer Ingelheim | 7 | $141 |
| Novo Nordisk | 8 | $132 |
| Lilly USA, LLC | 8 | $119 |
| Melinta Therapeutics, LLC | 3 | $62 |
| AstraZeneca | 4 | $59 |
| Novartis | 3 | $46 |
| Exact Sciences | 2 | $36 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $25 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $19 |
| Lexicon Pharmaceuticals, Inc. | 1 | $16 |
| GE HealthCare | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $13 |
| Astellas Pharma US Inc | 1 | $13 |
| GSK | 1 | $13 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
How this compares
$1,209 in reported general payments places this provider in the 95th percentile of 679 hospitalist providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 26 | $27,539 |
| EliquisApixaban | 11 | $14,644 |
| JardianceEmpagliflozin | 14 | $13,284 |
| JanuviaSitagliptin Phosphate | 11 | $5,905 |
| Levothyroxine Sodium | 52 | $578 |
| Amlodipine Besylate | 81 | $544 |
| Omeprazole | 37 | $451 |
| Gabapentin | 22 | $423 |
| Metoprolol Succinate | 26 | $379 |
| Atorvastatin Calcium | 47 | $378 |
| Losartan Potassium | 41 | $285 |
| Lisinopril | 55 | $273 |
| Fluticasone Propionate | 23 | $256 |
| Metoprolol Tartrate | 29 | $232 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $216 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $15 | $27,53926 claims |
| PfizerEliquis | $263 | $14,64411 claims |
| Boehringer IngelheimJardiance | $141 | $13,28414 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 679 hospitalist providers in Wisconsin.
Other hospitalist in Madison
- Eduard VasilevskisMadison$5K
- Trenton SnyderMadison$5K
- Andrew PapMadison$2K
- Eric HyunMadison$813
- Muhammad Bilal AbidMilwaukee$89K
- Aradhana PathakMilwaukee$45K
- Ankur SegonMilwaukee$35K
- Siddhartha SinghMilwaukee$26K
- Carlos MendezMilwaukee$18K
- Harsimran SekhonMilwaukee$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.